Role of gamma interferon and T cells in congenital Toxoplasma transmission

Parasite Immunology

Volumn 26, Issue 8-9, 2004, Pages 315-318

  Abou Bacar, A ^a,b   Pfaff, A W ^a   Letscher Bru, V ^a   Filisetti, D ^a   Rajapakse, R ^a   Antoni, E ^a   Villard, O ^a   Klein, J P ^a   Candolfi, E ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Balb c mice; CD8+ T cells; Congenital toxoplasmosis; Gamma interferon; Reinfection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; FEMALE; FETOPLACENTAL UNIT; FETUS; GESTATIONAL AGE; INTRAUTERINE INFECTION; MOUSE; NONHUMAN; PLACENTA; PREGNANT WOMAN; PRIMARY INFECTION; PRIORITY JOURNAL; REINFECTION; T LYMPHOCYTE; TOXOPLASMA GONDII;

EID: 13744250637     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00713.x     Document Type: Article

References (21)

1. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991; 146: 286-292.
2. Suzuki Y, Orellana MA, Schreiber RD & Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988; 240: 516-518.
3. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy, a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410-415.
4. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 1992; 149: 175-180.
5. Abou-Bacar A, Pfaff AW, Georges S, et al. Role of NK cells and IFN-gamma in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun 2004; 72: 1397-1401.
6. Remington JS, McLeod R & Desmonts G. In Infectious Diseases of the Fetus and New-born Infant, 4th edn., eds Remington JS, Klein OJ. Philadelphia: WB. Saunders Co; 1994: 141-267.
7. Roberts CW & Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitol 1992; 104: 19-23.
8. K haplotype. J Immunol 1986; 137: 2291-2297.
9. + T cells in murine resistance to street rabies virus. J Virol 1991; 65: 3429-3424.
10. + T cells. Infect Immun 1993; 61: 3730-3738.
11. + T cells in protective immunity to the murine nematode parasite Trichuris muris. Parasite Immunol 1995; 17: 161-165.
12. Mottram PL, Murray-Segal LJ, Han W, Maguire J, Stein-Oakley A & Mandel TE. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes 1998; 47: 1399-1405.
13. Morrison SG, Su H, Caldwell HD & Morrison RP. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun 2000; 68: 6979-6987.
14. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 1991; 147: 2310-2316.
15. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J Immunol 1991; 147: 3955-3959.
16. + T-helper and a T-killer cell. Nature 1998; 393: 474-478.
17. + effector function against intracellular infection. J Exp Med 1996; 184: 131-139.
18. Denkers EY & Sher A. Role of natural killer and NK1+ T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection. Biochem Soc Trans 1997; 25: 699-703.
19. Suzuki Y & Remington JS. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol 1990; 44: 1954-1956.
20. Denkers EY. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect 1999; 1: 699-708.
21. Dimier IH & Bout DT. Inhibition of Toxoplasma gondii replication in IFN-gamma-activated human intestinal epithelial cells. Immunol Cell Biol 1997; 75: 511-514.